# Eduard Auff

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eduard-auff/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,010 |
| Field | Botulinum Toxin and Related Neurological Disorders |
| h-index | 52 |
| i10-index | 128 |
| OpenAlex ID | https://openalex.org/A5011832110 |
| ORCID iD | 0000-0002-1438-8857 |
| Works | 232 |

## Researcher papers

- [A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease](https://scholariq.org/papers/a-mutation-in-vps35-encoding-a-subunit-of-the-retromer-complex-causes-late-onset/)
- [Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging](https://scholariq.org/papers/slow-expansion-of-multiple-sclerosis-iron-rim-lesions-pathology-and-7-t-magnetic/)
- [Variant in the sequence of the LINGO1 gene confers risk of essential tremor](https://scholariq.org/papers/variant-in-the-sequence-of-the-lingo1-gene-confers-risk-of-essential-tremor/)
- [Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.](https://scholariq.org/papers/double-blind-trial-of-botulinum-a-toxin-for-the-treatment-of-focal-hyperhidrosis/)
- [Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease](https://scholariq.org/papers/long-term-antidyskinetic-efficacy-of-amantadine-in-parkinson-s-disease/)
- [Neurological rehabilitation of severely disabled cardiac arrest survivors. Part II. Life situation of patients and families after treatment](https://scholariq.org/papers/neurological-rehabilitation-of-severely-disabled-cardiac-arrest-survivors-part/)
- [Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms](https://scholariq.org/papers/double-blind-trial-of-botulinum-a-toxin-for-the-treatment-of-focal-hyperhidrosis-2/)
- [Health-Related Quality of Life in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment and its Relation to Activities of Daily Living](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-subjective-cognitive-decline-and/)
- [Long-term safety and efficacy of teriflunomide](https://scholariq.org/papers/long-term-safety-and-efficacy-of-teriflunomide/)
- [Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients](https://scholariq.org/papers/treatment-of-focal-hyperhidrosis-with-botulinum-toxin-type-a-long-term-follow-up/)
- [Wanted: a better cut-off value for the Epworth Sleepiness Scale](https://scholariq.org/papers/wanted-a-better-cut-off-value-for-the-epworth-sleepiness-scale/)

## Researcher topics

- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Sympathectomy and Hyperhidrosis Treatments](https://scholariq.org/topics/sympathectomy-and-hyperhidrosis-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.